Source: Business Live UK

ViTel Net: Shield Therapeutics signs licence deal with Vital-Net to break into Japan

The Gateshead pharmaceutical firm has received an initial payment of $665,000 as part of the exclusive licence agreement

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Mark Noble's photo - CEO of ViTel Net

CEO

Mark Noble

CEO Approval Rating

82/100

Read more